OpenURL Connection Search

Select item for more details and to access through your institution.

The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.
Published in:
2019
By:
- Kramer, Iris;
- Schaapveld, Michael;
- Oldenburg, Hester S A;
- Sonke, Gabe S;
- McCool, Danielle;
- Leeuwen, Flora E van;
- Vijver, Koen K Van de;
- Russell, Nicola S;
- Linn, Sabine C;
- Siesling, Sabine;
- Oordt, C Willemien Menke-van der Houven van;
- Schmidt, Marjanka K;
- van Leeuwen, Flora E;
- Van de Vijver, Koen K;
- Menke-van der Houven van Oordt, C Willemien
Publication type:
journal article
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.
Published in:
2019
By:
- Dreijerink, Koen M A;
- Rijken, Johannes A;
- Compaijen, C J;
- Timmers, Henri J L M;
- van der Horst-Schrivers, Anouk N A;
- van Leeuwaarde, Rachel S;
- van Dam, P Sytze;
- Leemans, C René;
- van Dam, Eveline W C M;
- Dickhoff, Chris;
- Dommering, Charlotte J;
- de Graaf, Pim;
- Zwezerijnen, G J C;
- van der Valk, Paul;
- Menke-Van der Houven van Oordt, C Willemien;
- Hensen, Erik F;
- Corssmit, Eleonora P M;
- Eekhoff, E Marelise W
Publication type:
journal article
Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.
Published in:
Breast Cancer Research & Treatment, 2023, v. 197, n. 1, p. 161, doi. 10.1007/s10549-022-06732-y
By:
- Eijkelboom, Anouk H.;
- de Munck, Linda;
- Menke-van der Houven van Oordt, C. Willemien;
- Broeders, Mireille J. M.;
- van den Bongard, Desiree H. J. G.;
- Strobbe, Luc J. A.;
- Mureau, Marc A. M.;
- Lobbes, Marc B. I.;
- Westenend, Pieter J.;
- Koppert, Linetta B.;
- Jager, Agnes;
- Siemerink, Ester J. M.;
- Wesseling, Jelle;
- Verkooijen, Helena M.;
- Vrancken Peeters, Marie-Jeanne T. F. D.;
- Smidt, Marjolein L.;
- Tjan-Heijnen, Vivianne C. G.;
- Siesling, Sabine;
- The COVID and Cancer Care-NL Consortium;
- van Hoeve, J. C.
Publication type:
Article
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET.
Published in:
EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
By:
- Wijngaarden, Jessica E.;
- Jauw, Yvonne W. S.;
- Zwezerijnen, Gerben J. C.;
- de Wit-van der Veen, Berlinda J.;
- Vugts, Daniëlle J.;
- Zijlstra, Josée M.;
- van Dongen, Guus A. M. S.;
- Boellaard, Ronald;
- Menke-van der Houven van Oordt, C. Willemien;
- Huisman, Marc C.
Publication type:
Article
A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging.
Published in:
2020
By:
- Jager, Agnes;
- de Vries, Elisabeth G. E.;
- der Houven van Oordt, C. Willemien Menke-van;
- Neven, Patrick;
- Venema, Clasina M.;
- Glaudemans, Andor W. J. M.;
- Wang, Yamei;
- Bagley, Rebecca G.;
- Conlan, Maureen G.;
- Aftimos, Philippe
Publication type:
journal article
Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images.
Published in:
EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00444-4
By:
- Somasundaram, Ananthi;
- García, David Vállez;
- Pfaehler, Elisabeth;
- Jauw, Yvonne W. S.;
- Zijlstra, Josée M.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, Willemien C.;
- Huisman, Marc C.;
- de Vries, Elisabeth G. E.;
- Boellaard, Ronald
Publication type:
Article
89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.
Published in:
Cancers, 2023, v. 15, n. 23, p. 5546, doi. 10.3390/cancers15235546
By:
- Miedema, Iris H. C.;
- Wijngaarden, Jessica E.;
- Pouw, Johanna E. E.;
- Zwezerijnen, Gerben J. C.;
- Sebus, Hylke J.;
- Smit, Egbert;
- de Langen, Adrianus J.;
- Bahce, Idris;
- Thiele, Andrea;
- Vugts, Daniëlle J.;
- Boellaard, Ronald;
- Huisman, Marc C.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.
Published in:
Cancers, 2023, v. 15, n. 5, p. 1374, doi. 10.3390/cancers15051374
By:
- Bos, Manouk K.;
- Verhoeff, Sarah R.;
- Oosting, Sjoukje F.;
- Menke-van der Houven van Oordt, Willemien C.;
- Boers, Ruben G.;
- Boers, Joachim B.;
- Gribnau, Joost;
- Martens, John W. M.;
- Sleijfer, Stefan;
- van Herpen, Carla M. L.;
- Wilting, Saskia M.
Publication type:
Article
Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.
Published in:
Cancers, 2022, v. 14, n. 22, p. 5612, doi. 10.3390/cancers14225612
By:
- Werter, Inge M.;
- Remmelzwaal, Sharon;
- Burchell, George L.;
- de Gruijl, Tanja D.;
- Konings, Inge R.;
- van der Vliet, Hans J.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.
Published in:
Cancers, 2021, v. 13, n. 15, p. 3902, doi. 10.3390/cancers13153902
By:
- Geboers, Bart;
- Timmer, Florentine E. F.;
- Ruarus, Alette H.;
- Pouw, Johanna E. E.;
- Schouten, Evelien A. C.;
- Bakker, Joyce;
- Puijk, Robbert S.;
- Nieuwenhuizen, Sanne;
- Dijkstra, Madelon;
- van den Tol, M. Petrousjka;
- de Vries, Jan J. J.;
- Oprea-Lager, Daniela E.;
- Menke-van der Houven van Oordt, C. Willemien;
- van der Vliet, Hans J.;
- Wilmink, Johanna W.;
- Scheffer, Hester J.;
- de Gruijl, Tanja D.;
- Meijerink, Martijn R.
Publication type:
Article
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology.
Published in:
Cancers, 2021, v. 13, n. 10, p. 2304, doi. 10.3390/cancers13102304
By:
- Douma, Joeri A. J.;
- Buffart, Laurien M.;
- Sedhom, Ramy;
- Labots, Mariette;
- Menke-van der Houven van Oordt, Willemien C.;
- Skardhamar, Mikkjal;
- De Felice, Anthony;
- Lee, Esther;
- Dharmaraj, Divya;
- Azad, Nilofer S.;
- Carducci, Michael A.;
- Verheul, Henk M. W.;
- Mahadevan, Daruka
Publication type:
Article
RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.
Published in:
Molecular Oncology, 2019, v. 13, n. 11, p. 2361, doi. 10.1002/1878-0261.12550
By:
- Helden, Erik J.;
- Angus, Lindsay;
- Menke‐van der Houven van Oordt, C. Willemien;
- Heideman, Daniëlle A. M.;
- Boon, Eline;
- Es, Suzanne C.;
- Radema, Sandra A.;
- Herpen, Carla M. L.;
- Groot, Derk Jan A.;
- Vries, Elisabeth G. E.;
- Jansen, Maurice P. H. M.;
- Sleijfer, Stefan;
- Verheul, Henk M. W.
Publication type:
Article
How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans.
Published in:
EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00621-7
By:
- Wijngaarden, Jessica E.;
- Ahbari, Amina;
- Pouw, Johanna E. E.;
- Greuter, Henri N. J. M.;
- Bahce, Idris;
- Zwezerijnen, Gerben J. C.;
- Vugts, Daniëlle J.;
- van Dongen, Guus A. M. S.;
- Boellaard, Ronald;
- Menke-van der Houven van Oordt, C. Willemien;
- Huisman, Marc C.
Publication type:
Article
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study.
Published in:
EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00927-6
By:
- Wijngaarden, Jessica E.;
- Huisman, Marc C.;
- Pouw, Johanna E. E.;
- Menke-van der Houven van Oordt, C. Willemien;
- Jauw, Yvonne W. S.;
- Boellaard, Ronald
Publication type:
Article
Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example.
Published in:
EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00813-7
By:
- Huisman, Marc C.;
- Menke-van der Houven van Oordt, C. Willemien;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- van Dongen, Guus A. M. S.;
- Shah, Dhaval K.;
- Jauw, Yvonne W. S.
Publication type:
Article
Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00627-z
By:
- Mammatas, Lemonitsa H.;
- Venema, Clasina M.;
- Schröder, Carolina P.;
- de Vet, Henrica C. W.;
- van Kruchten, Michel;
- Glaudemans, Andor W. J. M.;
- Yaqub, Maqsood M.;
- Verheul, Henk M. W.;
- Boven, Epie;
- van der Vegt, Bert;
- de Vries, Erik F. J.;
- de Vries, Elisabeth G. E.;
- Hoekstra, Otto S.;
- Hospers, Geke A. P.;
- der Houven van Oordt, C. Willemien Menke-van
Publication type:
Article
Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.
Published in:
EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8
By:
- Jauw, Yvonne W. S.;
- Huisman, Marc C.;
- Nayak, Tapan K.;
- Vugts, Danielle J.;
- Christen, Randolph;
- Naegelen, Valerie Meresse;
- Ruettinger, Dominik;
- Heil, Florian;
- Lammertsma, Adriaan A.;
- Verheul, Henk M. W.;
- Hoekstra, Otto S.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1, doi. 10.2967/jnumed.124.267636
By:
- Eisses, Bertha;
- van Geel, Jasper J.L.;
- Brouwers, Adrienne H.;
- Bensch, Frederike;
- Elias, Sjoerd G.;
- Kuip, Evelien J.M.;
- Jager, Agnes;
- van der Vegt, Bert;
- Lub-de Hooge, Marjolijn N.;
- Emmering, Jasper;
- Arens, Anne I.J.;
- Zwezerijnen, Gerben J.C.;
- Vugts, Daniëlle J.;
- Menke-van der Houven van Oordt, C. Willemien;
- de Vries, Elisabeth G.E.;
- Schröder, Carolina P.;
- Bensch, F.;
- van Es, S.;
- van Essen-Eisses, B.;
- Boers, J.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- van Engen-van Grunsven, Ilse;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- Engen-van Grunsven, Ilse van;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- Menke-van der Houven van Oordt, Willemien C.;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- van Engen-van Grunsven, Ilse;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
By:
- Verhoeff, Sarah R.;
- van de Donk, Pim P.;
- Aarntzen, Erik H. J. G.;
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- Miedema, Iris H. C.;
- Voortman, Jens;
- van Oordt, Willemien C. Menke-van der Houven;
- Boellaard, Ronald;
- Vriens, Dennis;
- Slingerland, Marije;
- Hermsen, Rick;
- Grunsven, Ilse van Engen-van;
- Heskamp, Sandra;
- van Herpen, Carla M. L.
Publication type:
Article
11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251611
By:
- Mammatas, Lemonitsa H.;
- Yaqub, Maqsood;
- Hendrikse, N. Harry;
- Hoekstra, Otto S.;
- Honeywell, Richard J.;
- Schuit, Robert C.;
- Meijerink, Martijn;
- Schwarte, Lothar A.;
- Peters, Godefridus J.;
- Verheul, Henk M. W.;
- Lammertsma, Adriaan A.;
- Houven van Oordt, C. Willemien Menke-van der
Publication type:
Article
11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.251611
By:
- Mammatas, Lemonitsa H.;
- Yaqub, Maqsood;
- Hendrikse, N. Harry;
- Hoekstra, Otto S.;
- Honeywell, Richard J.;
- Schuit, Robert C.;
- Meijerink, Martijn;
- Schwarte, Lothar A.;
- Peters, Godefridus J.;
- Verheul, Henk M. W.;
- Lammertsma, Adriaan A.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
89Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
By:
- Jauw, Yvonne W. S.;
- O’Donoghue, Joseph A.;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- Willemien Menke-van der Houven van Oordt, C.;
- Morschhauser, Franck;
- Carrasquillo, Jorge A.;
- Zweegman, Sonja;
- Taskar, Neeta Pandit-;
- Lammertsma, Adriaan A.;
- van Dongen, Guus. A. M. S.;
- Boellaard, Ronald;
- Weber, Wolfgang A.;
- Huisman, Marc C.
Publication type:
Article
ImmunoPET imaging to assess target engagement: Experience from 89Zr‐anti‐HER3 mAb (GSK2849330) in patients with solid tumors.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.214726
By:
- Willemien Menke‐van der Houven van Oordt, C.;
- McGeoch, Adam;
- Bergstrom, Mats;
- McSherry, Iain;
- Smith, Deborah A.;
- Cleveland, Matthew;
- Al‐Azzam, Wasfi;
- Liangfu Chen;
- Verheul, Henk;
- Hoekstra, Otto S.;
- Vugts, Danielle J.;
- Freedman, Immanuel;
- Huisman, Marc;
- Matheny, Chris;
- Guus van Dongen;
- Sean Zhang
Publication type:
Article
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 902, doi. 10.2967/jnumed.118.214726
By:
- Menke-van der Houven van Oordt, C. Willemien;
- McGeoch, Adam;
- Bergstrom, Mats;
- McSherry, Iain;
- Smith, Deborah A.;
- Cleveland, Matthew;
- Al-Azzam, Wasfi;
- Liangfu Chen;
- Verheul, Henk;
- Hoekstra, Otto S.;
- Vugts, Danielle J.;
- Freedman, Immanuel;
- Huisman, Marc;
- Matheny, Chris;
- van Dongen, Guus;
- Sean Zhang
Publication type:
Article
Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Published in:
PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155178
By:
- van Helden, Erik J.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Roth, Chantal;
- Mulder, Emma R.;
- Verheul, Henk M. W.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
Published in:
Diagnostics (2075-4418), 2024, v. 14, n. 4, p. 416, doi. 10.3390/diagnostics14040416
By:
- Boers, Jorianne;
- Eisses, Bertha;
- Zwager, Mieke C.;
- van Geel, Jasper J. L.;
- Bensch, Frederike;
- de Vries, Erik F. J.;
- Hospers, Geke A. P.;
- Glaudemans, Andor W. J. M.;
- Brouwers, Adrienne H.;
- den Dekker, Martijn A. M.;
- Elias, Sjoerd G.;
- Kuip, Evelien J. M.;
- van Herpen, Carla M. L.;
- Jager, Agnes;
- van der Veldt, Astrid A. M.;
- Oprea-Lager, Daniela E.;
- de Vries, Elisabeth G. E.;
- van der Vegt, Bert;
- Menke-van der Houven van Oordt, Willemien C.;
- Schröder, Carolina P.
Publication type:
Article
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.
Published in:
Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596
By:
- de Vries, Bart M.;
- Golla, Sandeep S. V.;
- Zwezerijnen, Gerben J. C.;
- Hoekstra, Otto S.;
- Jauw, Yvonne W. S.;
- Huisman, Marc C.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, Willemien C.;
- Zijlstra-Baalbergen, Josée J. M.;
- Mesotten, Liesbet;
- Boellaard, Ronald;
- Yaqub, Maqsood
Publication type:
Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Published in:
NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
By:
- Mileva, Magdalena;
- de Vries, Elisabeth G. E.;
- Guiot, Thomas;
- Wimana, Zéna;
- Deleu, Anne-Leen;
- Schröder, Carolien P.;
- Lefebvre, Yolene;
- Paesmans, Marianne;
- Stroobants, Sigrid;
- Huizing, Manon;
- Aftimos, Philippe;
- Tol, Jolien;
- Van der Graaf, Winette T. A.;
- Oyen, Wim J. G.;
- Vugts, Danielle J.;
- Menke-van der Houven van Oordt, C. Willemien;
- Brouwers, Adrienne H.;
- Piccart-Gebhart, Martine;
- Flamen, Patrick;
- Gebhart, Géraldine
Publication type:
Article
Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
Published in:
Oncologist, 2017, v. 22, n. 8, p. 989, doi. 10.1634/theoncologist.2017-0019
By:
- van Prehn, Joffrey;
- Menke‐van der Houven van Oordt, C. Willemien;
- de Rooij, Madelon L.;
- Meijer, Ellen;
- Bomers, Marije K.;
- van Dijk, Karin
Publication type:
Article
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Published in:
Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01073-7
By:
- Eijkelboom, Anouk H.;
- de Munck, Linda;
- Vrancken Peeters, Marie-Jeanne T. F. D.;
- Broeders, Mireille J. M.;
- Strobbe, Luc J. A.;
- Bos, Monique E. M. M.;
- Schmidt, Marjanka K.;
- Guerrero Paez, Cristina;
- Smidt, Marjolein L.;
- Bessems, Maud;
- Verloop, Janneke;
- Linn, Sabine;
- Lobbes, Marc B. I.;
- Honkoop, Aafke H.;
- van den Bongard, Desirée H. J. G.;
- Westenend, Pieter J.;
- Wesseling, Jelle;
- Menke-van der Houven van Oordt, C. Willemien;
- Tjan-Heijnen, Vivianne C. G.;
- Siesling, Sabine
Publication type:
Article
PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
Published in:
Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202201043
By:
- Miedema, Iris H. C.;
- Zwezerijnen, Gerben J. C.;
- Huisman, Marc C.;
- Doeleman, Ellen;
- Mathijssen, Ron H. J.;
- Lammers, Twan;
- Hu, Qizhi;
- van Dongen, Guus A. M. S.;
- Rijcken, Cristianne J. F.;
- Vugts, Danielle J.;
- Menke‐van der Houven van Oordt, C. Willemien
Publication type:
Article
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
By:
- Wijngaarden, Jessica E.;
- Huisman, Marc C.;
- Jauw, Yvonne W. S.;
- van Dongen, Guus A. M. S.;
- Greuter, Henri N. J. M.;
- Schuit, Robert C.;
- Cleveland, Matthew;
- Gootjes, Elske C.;
- Vugts, Daniëlle J.;
- Menke-van der Houven van Oordt, C. Willemien;
- Boellaard, Ronald
Publication type:
Article
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2068, doi. 10.1007/s00259-023-06164-w
By:
- Miedema, Iris H.C.;
- Huisman, Marc C.;
- Zwezerijnen, Gerben J.C.;
- Grempler, Rolf;
- Pitarch, Alejandro Perez;
- Thiele, Andrea;
- Hesse, Raphael;
- Elgadi, Mabrouk;
- Peltzer, Alexander;
- Vugts, Danielle J.;
- van Dongen, Guus A.M.S.;
- de Gruijl, Tanja D.;
- Menke-van der Houven van Oordt, C. Willemien;
- Bahce, Idris
Publication type:
Article
Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
By:
- Jauw, Yvonne W. S.;
- Bensch, Frederike;
- Brouwers, Adrienne H.;
- Hoekstra, Otto S.;
- Zijlstra, Josée M.;
- Pieplenbosch, Simone;
- Schröder, Carolien P.;
- Zweegman, Sonja;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, C. Willemien;
- de Vries, Elisabeth G. E.;
- de Vet, Henrica C. W.;
- Boellaard, Ronald;
- Huisman, Marc C.
Publication type:
Article
Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Published in:
2018
By:
- Jauw, Yvonne W. S.;
- Heijtel, Dennis F.;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- de Vet, Henrica C. W.;
- Vugts, Danielle J.;
- Verheul, Henk M.;
- Boellaard, Ronald;
- Zweegman, Sonja;
- van Dongen, Guus A. M. S.;
- der Houven van Oordt, C. Willemien Menke-van;
- Lammertsma, Adriaan A.;
- Huisman, Marc C.
Publication type:
journal article
Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial.
Published in:
Current Oncology, 2022, v. 29, n. 9, p. 6186, doi. 10.3390/curroncol29090486
By:
- Schuit, Anouk S.;
- Holtmaat, Karen;
- Coupé, Veerle M. H.;
- Eerenstein, Simone E. J.;
- Zijlstra, Josée M.;
- Eeltink, Corien;
- Becker-Commissaris, Annemarie;
- van Zuylen, Lia;
- van Linde, Myra E.;
- Menke-van der Houven van Oordt, C. Willemien;
- Sommeijer, Dirkje W.;
- Verbeek, Nol;
- Bosscha, Koop;
- Nandoe Tewarie, Rishi;
- Sedee, Robert-Jan;
- de Bree, Remco;
- de Graeff, Alexander;
- de Vos, Filip;
- Cuijpers, Pim;
- Verdonck-de Leeuw, Irma M.
Publication type:
Article

Found: 39

The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.

Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.

Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using <sup>18</sup>F-FES PET/CT imaging.

Noise sensitivity of <sup>89</sup>Zr-Immuno-PET radiomics based on count-reduced clinical images.

89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.

Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology.

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.

How to obtain the image-derived blood concentration from <sup>89</sup>Zr-immuno-PET scans.

Optimal imaging time points considering accuracy and precision of Patlak linearization for <sup>89</sup>Zr-immuno-PET: a simulation study.

Potential and pitfalls of <sup>89</sup>Zr-immuno-PET to assess target status: <sup>89</sup>Zr-trastuzumab as an example.

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.

<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.

<sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

ImmunoPET imaging to assess target engagement: Experience from 89Zr‐anti‐HER3 mAb (GSK2849330) in patients with solid tumors.

Immuno-PET Imaging to Assess Target Engagement: Experience from <sup>89</sup>Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors.

Early <sup>18</sup>F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.

Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.

Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.

<sup>89</sup>Zr-immuno-PET using the anti-LAG-3 tracer [<sup>89</sup>Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.

Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.

Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial.